Alaunos Therapeutics Inc (TCRT)
2.39
+0.07
(+3.02%)
USD |
NASDAQ |
Nov 22, 16:00
2.355
-0.04
(-1.46%)
After-Hours: 20:00
Alaunos Therapeutics Free Cash Flow: -11.76M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -11.76M |
| June 30, 2024 | -17.36M |
| March 31, 2024 | -22.68M |
| December 31, 2023 | -30.34M |
| September 30, 2023 | -30.20M |
| June 30, 2023 | -29.98M |
| March 31, 2023 | -31.09M |
| December 31, 2022 | -29.45M |
| September 30, 2022 | -37.69M |
| June 30, 2022 | -41.48M |
| March 31, 2022 | -56.56M |
| December 31, 2021 | -64.79M |
| September 30, 2021 | -70.11M |
| June 30, 2021 | -78.24M |
| March 31, 2021 | -72.40M |
| December 31, 2020 | -66.79M |
| September 30, 2020 | -57.70M |
| June 30, 2020 | -50.65M |
| March 31, 2020 | -41.32M |
| December 31, 2019 | -41.14M |
| September 30, 2019 | -41.16M |
| June 30, 2019 | -38.80M |
| March 31, 2019 | -41.05M |
| December 31, 2018 | -49.92M |
| September 30, 2018 | -50.62M |
| Date | Value |
|---|---|
| June 30, 2018 | -54.73M |
| March 31, 2018 | -59.88M |
| December 31, 2017 | -55.41M |
| September 30, 2017 | -56.12M |
| June 30, 2017 | -57.65M |
| March 31, 2017 | -57.28M |
| December 31, 2016 | -58.88M |
| September 30, 2016 | -69.92M |
| June 30, 2016 | -10.40M |
| March 31, 2016 | -6.924M |
| December 31, 2015 | -0.422M |
| September 30, 2015 | 13.90M |
| June 30, 2015 | -41.89M |
| March 31, 2015 | -37.92M |
| December 31, 2014 | -36.84M |
| September 30, 2014 | -36.03M |
| June 30, 2014 | -40.95M |
| March 31, 2014 | -49.94M |
| December 31, 2013 | -59.64M |
| September 30, 2013 | -72.16M |
| June 30, 2013 | -71.74M |
| March 31, 2013 | -72.73M |
| December 31, 2012 | -80.39M |
| September 30, 2012 | -72.91M |
| June 30, 2012 | -69.34M |
Free Cash Flow Range, Past 5 Years
-78.24M
Minimum
Jun 2021
-11.76M
Maximum
Sep 2024
-44.09M
Average
-41.23M
Median
Free Cash Flow Benchmarks
| Microbot Medical Inc | -8.97M |
| SELLAS Life Sciences Group Inc | -33.07M |
| Galectin Therapeutics Inc | -33.68M |
| Oragenics Inc | -7.682M |
| Anavex Life Sciences Corp | -30.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.781M |
| Free Cash Flow Per Share (Quarterly) | -0.4877 |
| Free Cash Flow Yield | -307.4% |